Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics

• Mark S Cragg ,

  *To whom correspondence should be addressed. E-mail: msc@soton.ac.uk (MSC); strasser@wehi.edu.au (AS)

  Current address: Cancer Sciences Division, Southampton University, Southampton, United Kingdom

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

  ⨯
• Junya Kuroda,

  Current address: Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

  ⨯
• Hamsa Puthalakath,

  Current address: Department of Biochemistry, La Trobe University, Bundoora, Victoria, Australia

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

  ⨯
• David C. S Huang,

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

  ⨯
• Andreas Strasser

  *To whom correspondence should be addressed. E-mail: msc@soton.ac.uk (MSC); strasser@wehi.edu.au (AS)

  Affiliation The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

  ⨯